New York University
New York University is a private research university anchored around Washington Square in Greenwich Village, with a $1.5 billion research enterprise and one of the most commercially productive tech-transfer track records in U.S. academia, most famously the Remicade antibody franchise.
Commercialization Approach
Technology Opportunities and Ventures translates the outputs of the university research base into commercial solutions and technologies to maximize their social and economic impact.
Research Focus Areas
Biomedical & Translational Medicine
Clinical and therapeutic research driving the bulk of NYU commercialization
Computer Science, AI & Mathematics
Foundational quantitative and computing research
Neuroscience & Precision Psychiatry
Brain and behavioral research feeding precision-psychiatry spinouts
Related Market Maps
Explore market opportunities in deep tech categories relevant to NYU's research focus.
View all market maps →Notable Spinouts
Alto Neuroscience
Founded 2020 • Biotechnology
Precision-psychiatry biopharma using brain biomarkers to target depression and PTSD therapies
Ajax Therapeutics
Founded 2019 • Biotechnology
Structure-based precision therapies for myeloproliferative and blood disorders
Visit siteAethon Therapeutics
Founded 2022 • Biotechnology
Custom antibody therapeutics with a novel approach to fighting cancer
Programs & Resources
NYU Entrepreneurial Institute
centerUniversity-wide hub for startup education, venture support, and the Endless Frontier Labs accelerator
Learn moreRankings & Recognition
Tech Transfer Office
NYU Technology Opportunities & Ventures (TOV)
Director: Marc Sedam
IP Portfolio Available
Platform: e-lucid
Browse IP PortfolioServices Offered
- •Technology licensing
- •Startup formation and venture support
- •Corporate-sponsored research facilitation
Interested in Tech Transfer?
Learn how to navigate university licensing and commercialization